Mount Sinai Health System
Mount Sinai Health System and Renalytix AI afnnounced the formation of Kantaro Biosciences, a Mount Sinai venture, to develop and scale production and distribution of a test kit based on the Mount Sinai-developed high-performance serologic assay for SARS-CoV-2 antibodies.
Rankings by
National Ranking36th
in United States Regional Ranking40th
in North America and Caribbean Global Ranking89th
worldwide